What is the current market price of rubicatin (rubitidine)? Price Trends and Market Forecasts to 2025

As of 2025, the price of Lurbinectedin, a chemotherapy drug used to treat advanced small cell lung cancer, shows certain differences in the global market. The specific selling price is affected by factors such as region, drug supply, exchange rate fluctuations, etc. The original drug of Rubicatin has not yet been officially launched in mainland China, but its selling price in Hong Kong and other overseas markets has attracted public attention, especially in the price trend in 2025, which has a certain degree of volatility.

In the Hong Kong market, the original drug of Rubicatin (4mg per box) is priced at more than 20,000 yuan, which is an estimated price based on the latest exchange rate. Since the drug is an imported drug, the price is usually higher, and exchange rate fluctuations will also directly affect the final selling price. Therefore, patients need to pay attention to exchange rate changes in the international market when purchasing to avoid increased costs due to exchange rate fluctuations. At the same time, since rubicatin, as a new anti-cancer drug, is still in the high-end drug market, the price is still relatively expensive, and no generic drugs have yet appeared on the market.

For the American version of Ruby Cardin, the price is even higher, with each box selling for about 90,000 yuan. This price level is based on the selling price in the U.S. market, and prices may fluctuate as drug supply, insurance policies and other factors change. The price of the Singapore version of Rubicatin is slightly cheaper, about more than 30,000 yuan per box, but it is still higher than the average patient's affordability. In 2025, the price of Rubicatin is expected to remain at a high level in the European, American and Asian markets. Since drug production costs and related R&D investments have not yet been recovered, the price of the original drug is still in the expensive range.
Since Rubicatin has not yet launched generic drugs on the market, only the original drug is currently available. As demand for the drug increases in more countries, the market may be undersupplied, which may also affect the price trend of the drug. In the next few years, as the drug is gradually promoted in the global market, it is expected that some pharmaceutical companies may begin to study generic versions, which may have a certain suppressive effect on prices. However, until generics become available, rubicatin will still maintain a high market price.
Reference: https://www.zepzelca.com/